Cristen Flewellen, a second-year Meharry medical student, was awarded Third Place in the Community Research category at the 67th Annual Meharry Student Research Day for her work with the Breast cancer Risk Assessment- achieVing Equity (BRAVE) study funded through the Meharry Vanderbilt Tennessee State Cancer Partnership (MVTCP). The BRAVE study PIs are Lucy Spalluto, MD
The meeting theme: “Building on a Solid Foundation to Strategically Strengthen and Enhance PACHE.” The gathering brought together PACHE (U54/P20) investigators, Program Managers, and NCI/CRCHD staff to discuss progress made by the program as well as topics that are important for the continued growth of PACHE. Photo of MVTCP Leadership: C. Whitted(MVA), L. Stewart(MMC), A.
The Community Outreach Core (COC) of the Meharry Vanderbilt Tennessee State Cancer Partnership (MVTCP) has updated the request for support services online form. If you have questions or needs, the expert faculty of the COC is available for consultation. Use the link below to complete the request form: https://redcap.link/osixjxly
A new study authored by Vishal R. Patel, BS, Dr. Alex B. Haynes, MD, MPH (Dell Medical School, The University of Texas at Austin), Dr. Karen Winkfield, M.D., PhD (Meharry-Vanderbilt Alliance, Vanderbilt University Medical Center, Nashville, TN), Dr. Arjun Gupta, MD, Dr. Anne H. Blaes, MD, MS (Masonic Cancer Center, University of Minnesota, Minneapolis), Dr.
Dr. Kunle Odunsi, MD, PhD,a new member of the Meharry Vanderbilt Tennessee State Cancer Partnership (MVTCP) Program Steering Committee, will present at the upcoming Flexner Discovery Lecture, hosted by theVanderbilt-Ingram Cancer Center (VICC) Medical Scientist Training Program. Dr. Odunsi is the Director of the Comprehensive Cancer Center, Dean for Oncology, and AbbVie Distinguished Service Professor
On Saturday, February 25, the Meharry-Vanderbilt-Tennessee State University Cancer Partnership (MVTCP) hosted the 22nd Annual MVTCP Symposium entitled “Cancer Health Disparities: From Bench to Bedside to Community.” Faculty members from Meharry Medical College, Vanderbilt University Medical Center, Tennessee State University, and members of the Nashville community joined together at Meharry’s West Basic Sciences Building to
Please join for the final presentation of the spring 2022 Genomics and Personalized Medicine seminar next week. Jeffrey N. Weitzel, MD Vice President of Medical Affairs, Hereditary Cancer, Natera Professor, Latin American School of Oncology “Addressing global implementation of genomic cancer risk assessment – Lessons learned in Latin America” May 3, 2022 2-3PM Please click
Since the pandemic, 1 in 8 adults including 1 in 7 children struggle with hunger every day in Middle Tennessee. Hunger is closer than you think, but so is the solution. Currently, Second Harvest is experiencing a startling increase in need and more people than ever are using the food bank’s resources for the first
